Market Overview

Colgate-Palmolive Set To Outperform In 2018, According To Macquarie

Colgate-Palmolive Set To Outperform In 2018, According To Macquarie
Related CL
Paws Up: The First Pets ETF Is Here
Jim Cramer Weighs In On Biogen, Colgate-Palmolive And More

Colgate-Palmolive Company (NYSE: CL) isn't necessarily the most exciting name for investors to talk about, but heading into 2018 the case can be made to be buyers of the stock.

The Analyst

Macquarie Research's Caroline Levy upgraded Colgate-Palmolive's stock from Neutral to Outperform with a price target boosted from $71 to $81.

The Thesis

Heading into 2018, Colgate-Palmolive's business is at a "turning point" for multiple reasons, Levy said in a note, such as improvement in the U.S. business (30 percent of total sales), foreign exchange rates now neutral if not positive, and the company will "lap" one-time events (i.e., earthquake and hurricanes in Mexico and the Caribbean) across the world.

Colgate-Palmolive is boosting its advertising spend after a heavy schedule of new product launches throughout the bottom half of 2017, Levy said. This should help support sales growth in 2018 while the company's 31 percent tax rate is "well above" the average for a global company and should fall under the proposed tax reform plan.

Colgate-Palmolive's high margins and high returns makes it a potential takeover candidate although it's impossible to know if a deal will happen, Levy added. Nevertheless, the company is an appealing target which would "keep upward pressure" on the stock so long as chatter remains ongoing.

Price Action

Shares of Colgate-Palmolive gained more than 1.7 percent Tuesday.

Related Links:

3 Most Likely Suitors For Colgate-Palmolive, In Jefferies' View

Morgan Stanley Catches Flack For Colgate-Palmolive Upgrade

Latest Ratings for CL

Oct 2018Morgan StanleyMaintainsEqual-WeightEqual-Weight
Oct 2018ArgusMaintainsBuyBuy
Oct 2018SunTrust Robinson HumphreyDowngradesBuyHold

View More Analyst Ratings for CL
View the Latest Analyst Ratings

Posted-In: Caroline Levy Conglomerates Macquarie ResearchAnalyst Color Upgrades Price Target Analyst Ratings Best of Benzinga


Related Articles (CL)

View Comments and Join the Discussion!

Latest Ratings

CPAImperial CapitalDowngrades68.0
PRMWImperial CapitalInitiates Coverage On18.0
TGTKeyBancInitiates Coverage On110.0
QCOMMorgan StanleyUpgrades0.0
View the Latest Analytics Ratings
Don't Miss Out!
Join Our Newsletter
Subscribe to:
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Fintech Focus
Your weekly roundup of hot topics in the exciting world of fintech.
Thank You
for registering for Benzinga’s newsletters and alerts.
• The Daily Analysts Ratings email will be received daily between 7am and 10am.
• The Market in 5 Minutes email will be received daily between 7am and 8am.
• The Fintech Focus email will be received every Friday between 2pm and 5pm.

Mid-Afternoon Market Update: NASDAQ Down 0.5%; China Recycling Energy Shares Spike Higher

GM Notches Upgrade On 'Resiliency,' Next-Gen Mobility